Medical Cannabis for Chronic Pain: Options Compared by Evidence
How medical cannabis for chronic pain compares by evidence, dose control, onset, and access, with pros, cons, and the best product type for each use case.
Medical cannabis vs opioid painkillers for chronic pain
Two drug classes treat chronic pain. They differ in evidence, death risk, dependence rates, cost, and legal status. Here is the pick, then the options.
The pick: medical cannabis first for most chronic non-cancer pain
A 2017 National Academies review found conclusive or substantial evidence that cannabis reduces chronic pain in adults. Opioid trials for the same condition show a modest drop in pain scores against placebo, and Cochrane reviews rate that evidence as low to moderate quality. The risk gap between the two classes is wider than the benefit gap. The CDC counted 81,806 opioid-involved overdose deaths in the US in 2022. Cannabis has no confirmed lethal overdose dose. That number alone drives the ordering.
cannabis topicals for chronic joint pain
Dependence exists on both sides. NIDA puts cannabis use disorder at about 9% of adults who use cannabis, and 17% for people who start in their teens. Among chronic pain patients prescribed opioids, 8% to 12% develop opioid use disorder. Pick cannabis first, but screen for personal or family history of psychosis and for heart disease.
Cannabis Edibles Dosage for Chronic Pain Management Guide
Where opioids still win
Acute pain after surgery, cancer pain, and pain at the end of life. Opioids act in minutes, come in IV form, and carry 60 years of dosing data. Insurance covers them. A monthly opioid prescription often costs a $10 to $40 copay. Medical cannabis runs $100 to $400 per month out of pocket, and no US insurer covers it. Cost is the main reason patients stay on opioids.
medical cannabis for chronic pain vs opioid painkillers
Options: cannabis formats for chronic pain
Format sets onset and duration far more than strain names do. Most US medical programs dispense oil, not flower. A 1:1 THC to CBD ratio is the common starting point in pain trials.
- Inhaled flower or vape: onset 1 to 10 minutes, duration 2 to 3 hours. Easiest to titrate. Hard on the lungs.
- Oral tincture or oil: onset 30 to 90 minutes, duration 4 to 8 hours. Best fit for steady all-day relief.
- Capsule or edible: onset 60 to 120 minutes, duration 6 to 8 hours. Tight dose per unit, loose onset control.
- Topical: no psychoactive effect. Evidence for joint pain is thin.
Opioid options, in context
Schedule II drugs: hydrocodone, oxycodone, morphine, tramadol. All cause constipation, tolerance, and respiratory depression at high doses. Naloxone reverses an overdose. Any opioid supply should sit next to naloxone.
Numbers to know
- 81,806 opioid overdose deaths in the US in 2022 (CDC).
- No confirmed lethal overdose deaths from cannabis alone (CDC, NIDA).
- More than 35 states plus DC run medical cannabis programs.
- Opioid prescribing peaked in 2012 at 81 prescriptions per 100 people. By 2020 it was 43 per 100 (CDC).
What is unknown
Long-term cannabis data past 2 years is thin. Vaping lung injury risk is not settled. Federal law still lists cannabis as Schedule I, so research is limited and insurers stay out. Ask a clinician before mixing cannabis with opioids, benzodiazepines, or blood thinners. THC raises heart rate and competes with drugs metabolized by CYP450 enzymes.